Trial intelligence / Profile preview

PLATO teicoplanin population pharmacokinetics study in ICU and hematology patients

NL-OMON49412Active, not recruiting

Sponsor
Radboud University Medical Center
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of teicoplanin in Gram-positive bacterial infection, Staphylococcosis, Staphylococcus aureus infection and 1 more, sponsored by Radboud University Medical Center. Started Dec 2019; status: active, not recruiting.

02

Drugs

teicoplanin
03

Conditions

Gram-positive bacterial infectionStaphylococcosisStaphylococcus aureus infectioncoagulase-negative staphylococcal infection (CoNS)

Beyond the preview

Go deeper on NL-OMON49412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call